ECE2023 Poster Presentations Thyroid (163 abstracts)
1Ankara City Hospital, Endocrinology and Metabolism, Ankara, Turkey; 2Ankara City Hospital, Pathology, Ankara, Turkey; 3Ankara Yildirim Beyazit University Faculty of Medicine, Endocrinology and Metabolism, Ankara, Turkey
Aim: To determine whether there is any factor that can predict sufficient results in second thyroid fine-needle aspiration biopsy (FNAB) after first nondiagnostic cytological result.
Materials and method: Nodules with non-diagnostic result after first FNAB were included and separated into two groups as sufficient (Group-1) and insufficient (Group-2) second FNAB.
Results: Second FNAB was performed on 643 nodules of 443 patients with initial nondiagnostic cytology. The result was diagnostic in 437(68.0%) nodules (Group-1) while it was again nondiagnostic in 206(32.0%) (Group-2). Thyroid autoantibody positivity were similar in groups. Cystic/mixed structure and heterogeneous echogenity were more frequent in Group-2 (P=0.020 and P=0.011, respectively). Solid structure and isoechoic appearence were more frequent in Group-1 (P=0.003 and P=0.020, respectively). Border regularity, micro/macrocalcification, taller-than-wide shape, presence of halo were comparable in two groups (P>0.05). There were also no significant differences in terms of nodule dimensions, volume and rate of subcentimeter nodule between two groups(P>0.05). In multivariate analysis, likelihood of sufficient cytology was 1.943 times higher in isoechoic nodules in comparison to heterogeneous nodules(95 CI:1.253-2.977, P=0.003), whereas the effect of nodule structure on sufficient result became insignificant(P=0.432). Sufficient results group were cytologically distributed as 299 (68.4%) benign, 131 (30.0%) AUS/FLUS, 2 (0.5%) FN/SFN, 1 (0.2%) SFM and 4 (0.9%) malignant. 35 patients in Group-1 and 20 patients in Group-2 underwent thyroidectomy. Malignant histopathology was observed in 12/60(20%) nodules in Group-1 and in 3/37(8.1%) nodules in Group-2 (P=0.116)(Table).
Sufficient result after nondiagnostic biopsy (n=437, 68.0%) | Insufficient result after nondiagnostic biopsy (206, 32.0%) | P | AntiTPO positivity (n=606) | 85 (20.6%) | 28 (14.5%) | 0.074 |
Anti-TG positivity (n=600) | 89 (21.8%) | 33 (17.3%) | 0.204 |
Subcentimeter nodule | 35 (8.0%) | 18 (8.8%) | 0.747 |
Taller-than-wider | 51 (11.7%) | 15 (7.3%) | 0.085 |
Irregular border (n=304) | 188 (89.5%) | 77 (81.9%) | 0.067 |
Echogenity (n=587) | 0.005 | ||
Isoechoic | 314 (77.3%) | 118 (64.5%) | 0.001 |
Hypoechoic | 26 (6.4%) | 18 (9.8%) | 0.143 |
Heterogenous | 66 (16.3%) | 47 (25.7%) | 0.0071 |
Nodule texture | 0.038 | ||
solid | 404 (92.4%) | 180 (87.4%) | |
cystic/mixt | 33 (7.6%) | 26 (12.6%) | |
Microcalcification | 26 (5.9%) | 8 (3.9%) | 0.275 |
Macrocalcification | 36 (8.2%) | 21 (10.2%) | 0.415 |
Presence of halo | 72 (16.5%) | 26 (12.6%) | 0.204 |
Histopathology, malignant (n=97) | 12 (20.0%) | 3 (8.1%) | 0.116 |
Nodule Dimensions (mm, median (IQR)) | |||
Anteroposterior | 8.8 (7.0-12.6) | 9.1 (6.8-12.8) | 0.780 |
Lateral | 11.9 (9.5-16.2) | 11.8 (9.3-16.6) | 0.948 |
Longitudinal | 13.1 (10.9-19.4) | 13.6 (10.7-19.1) | 0.804 |
Nodule Volume (cm3, median (IQR)) | 0.71 (0.39-2.03) | 0.69 (0.37-1.91) | 0.993 |
IQR:interquartile range |
Conclusions: Heterogeneous echogenity and cystic/mixt structure were more frequent in insufficient group, but after multivariate analysis, only isoechoic texture was determined to predict sufficient cytological result in rebiopsy. Second biopsy should be done to all nondiagnostic nodules because of comparable malignant histopathology results.